DOI QR코드

DOI QR Code

Pharmaceutical Devices for Oral Cavity-based Local and Systemic Drug Delivery

  • Yun, Gyi-Ae (Department of Food Science and Technology, Chung-Ang University) ;
  • Choi, Sung-Up (Division of Pharmaceutics, College of Pharmacy, Chung-Ang University) ;
  • Park, Ki-Hwan (Department of Food Science and Technology, Chung-Ang University) ;
  • Rhee, Yun-Seok (School of Pharmacy, Sungkyunkwan University) ;
  • Lee, Beom-Jin (Bioavailability Control Laboratory, College of Pharmacy, Kangwon National University) ;
  • Lee, Jae-Hwi (Division of Pharmaceutics, College of Pharmacy, Chung-Ang University)
  • Received : 2010.08.24
  • Accepted : 2010.10.07
  • Published : 2010.12.20

Abstract

Pharmaceutical technology has primarily focused on the development of the best dosage forms depending on the route of administration. The design of dosage forms is greatly influenced by the route of administration. Due to a variety of advantages such as avoidance of first-pass effect, abundant blood supply and easy access to the absorption site, the oral cavity has frequently been selected as a site for drug delivery. Since the oral cavity is relatively unique from the anatomical and physiological viewpoint, one should always consider these conditions when designing the drug delivery systems for the oral cavity. In this regard, the current review paper was prepared to summarize the essential features of the drug delivery systems utilized in the oral cavity, along with the introduction of various dosage forms developed to date.

Keywords

References

  1. Anders, R., Merkle, H.P., 1989. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 49, 231-240. https://doi.org/10.1016/0378-5173(89)90347-5
  2. Beyssac, E., Touaref, F., Aiache, J-M., Sandouk, P., Haguenauer, D., 1994. In vivo evaluation of a bioadhesive controlled release buccal morphine tablet. Proceed. Int. Symp. Control. Rel. Bio. Mater. 21, 553-554.
  3. Bottenberg, P., De Muynck, C., Bouckaert, S., Cleymaet, R., Coomans, D., Slop, D., Remon, J.P., 1991. Development and testing of bioadhesive, fluoride-containing slow release tablets for oral use, Part II: In vivo fluoride release. Proceed. Int. Symp. Control. Rel. Bio. Mater. 18, 636-637.
  4. Bremecker, K-D., Strempel, H., Klein, G., 1984. Novel concept for a mucosal adhesive ointment. J. Pharm. Sci. 73, 548-552. https://doi.org/10.1002/jps.2600730429
  5. DeGrande, G., Benes, L., Horriere, F., Karsenty, H., Lacoste, C., McQuinn, R., Guo, J.-H., Scherrer, R., 1996. Specialized oral mucosal drug delivery systems: Patches. In: Oral Mucosal Drug Delivery, Marcel Dekker, New York.
  6. de Vries, M.E., Bodde, H.E., Verhoef, J.C., Junginger, H.E., 1991. Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 8, 271-303.
  7. Engstrom, S., Ljusberg-Wahren, H., Gustafsson, A., (1995). Bioadhesive properties of the monoolein-water system. Pharm. Tech. Eur. 7, 14-17.
  8. Gandhi, R.B., Robinson, J.R., 1994. Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Del. Rev. 13, 43-74. https://doi.org/10.1016/0169-409X(94)90026-4
  9. Gou, J-H., 1994. Bioadhesive polymer buccal patches for buprenorphine controlled delivery: Formulation, in-vitro adhesion and release properties. Drug Dev. Ind. Pharm. 20, 2809-2821. https://doi.org/10.3109/03639049409042682
  10. Ishida, M., Nambu, N., Nagai, T., 1983. Ointment-type oral mucosal dosage form of Carbopol containing prednisolone for treatment of aphtha. Chem. Pharm. Bull. 31, 1010-1014. https://doi.org/10.1248/cpb.31.1010
  11. Karsenty, H., Chau, I., Lacoste, C., Benes, L., Horriere, F., Degrande, G., 1994. Safety profile and patient acceptance of an original transmucosal delivery system. Proceed. Int. Symp. Control. Rel. Bio. Mater. 21, 549-550.
  12. Kellaway, I.W., Warren, S.J., 1991. Mucoadhesive hydrogels. Proceed. Int. Symp. Control. Rel. Bio. Mater. 18, 73-74.
  13. Langoth, N., Kalbe, J., Bernkop-Schnurch, A., 2003. Development of buccal drug delivery systems based on a thiolated polymer. Int. J. Pharm. 252, 141-148. https://doi.org/10.1016/S0378-5173(02)00638-5
  14. Lee, Y., Chien, Y.W., 1995. Oral mucosa controlled delivery of LHRH by bilayer mucoadhesive polymer systems. J. Control. Release 37, 251-261. https://doi.org/10.1016/0168-3659(95)00082-8
  15. Li, C., Bhatt, P.P., Johnston, T.P., 1997. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm. Dev. Tech. 2, 265-274. https://doi.org/10.3109/10837459709031446
  16. Medlicott, N.J., Rathbone, M.J., Tucker, I.G., Holborow, D.W., 1994. Delivery systems for the administration of drugs to the periodontal pocket. Adv. Drug Del. Rev. 13, 181-203. https://doi.org/10.1016/0169-409X(94)90033-7
  17. Merkle, H.P., Anders, R., Wermerskirchen, A., Raehs, S., Wolany, G., 1990. Buccal routes of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery, Marcel Dekker, New York.
  18. Minghetti, P., Montanari, L., 1995. Buccoadhesive two-layer tablet for topical delivery of acitretin. Proceed. 1st World Meeting of APGI/APV, Budapest, 753-754.
  19. Nagai, T., Konishi, R., 1987. Buccal/gingival drug delivery systems. J. Control. Release 6, 353-360. https://doi.org/10.1016/0168-3659(87)90088-5
  20. Nantwi, P.K.K., Cook, D.J., Rogers, D.J., Smart, J.D., 1997. Lectins for drug delivery within the oral cavity - Investigation of lectin binding to oral mucosa. J. Drug Target. 5, 45-55. https://doi.org/10.3109/10611869708995857
  21. Pongjanyakul, T., Suksri, H., 2009. Alginate-magnesium aluminium silicate films for buccal delivery of nicotine. Coll. Surf. B: Biointerf. 74, 103-113. https://doi.org/10.1016/j.colsurfb.2009.06.033
  22. Rassing, M.R., 1996. Specialized oral mucosal drug delivery systems: Chewing gum. In: Oral Mucosal Drug Delivery, Marcel Dekker, New York.
  23. Rathbone, M.J., Drummond, B.K., Tucker, I.G., 1994. The oral cavity as a site for systemic drug delivery. Adv. Drug Del. Rev. 13, 1-22. https://doi.org/10.1016/0169-409X(94)90024-8
  24. Remunan-Lopez, C., Portero, A., Vila-Jato, J.L., Alonso, M.J., 1998. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release 55, 143-152. https://doi.org/10.1016/S0168-3659(98)00044-3
  25. Shojaei, A., Li, X., 1997. Determination of transport route of acyclovir across buccal mucosa. Proceed. Int. Symp. Control. Rel. Bio. Mater. 24, 427-428.
  26. Tsutsumi, K., Takayama, K., Machida, Y., Ebert, C.D., Nakatomi, I., Nagai, T., 1994. Formulation of buccal mucoadhesive dosage form of ergotamine tartrate. STP Pharm. Sci. 4, 230-234.
  27. Utoguchi, N., Watanabe, Y., Matsumoto, M., 1996. Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa. Proceed. Int. Symp. Control. Rel. Bio. Mater. 23, 249-250.
  28. Vyas, S.P., Jain C.P., 1992. Bioadhesive polymer-grafted starch micospheres bearing isosorbide dinitrate for buccal administration. J. Microencap. 9, 457-464. https://doi.org/10.3109/02652049209040484
  29. Yang, B., Knutson, K., 1992. Buccal delivery system for polar solutes. Proceed. Int. Symp. Control. Rel. Bio. Mater. 19, 409-410.
  30. Zhang, H., Robinson, J.R., 1996. Routes of drug transport across oral mucosa. In: Oral Mucosal Drug Delivery, Marcel Dekker, New York.